| 
                            
                                | Tapentadol-ß-D-glucuronide, | T-060 |  
                                | 100 ug/mL in 1:1 Acetonitrile:Water 
 The first Certified Spiking Solution® of the primary urinary metabolite of tapentadol. Tapentadol is the first new drug of the centrally-acting analgesic class approved in the US for pain management in more than 25 years. This new Certified Spiking Solution® is suitable for many LC/MS or GC/MS applications, including pain prescription monitoring, forensic testing, clinical toxicology, or urine drug testing.
 |  | 
 |  |